Choosing appropriate chemoprophylaxis and stand-by treatment for
travelers will remain a problem for the near future because of resistant
Plasmodium falciparum. For those who live in the malaria endemic regions
of the world it is a matter of life and death, but the future looks
bright for control of malaria because of the development of
organizations like MMV and their ability to forge suitable partnerships
to tackle really big problems. This would not be possible if it were not
for the MMV Stakeholders who provide the funding necessary for the
discovery and development of new drugs. Malaria is a difficult problem
but even if only a few of the potential drugs in the MMV pipeline become
drugs, the control of malaria may again become possible.
Medicines for malaria venture new developments in antimalarials, Travel Medicine and Infectious Disease, 2, 161-170. doi:10.1016/j.tmaid.2004.03.002
Medicines for malaria venture new developments in antimalarials.